An open-label study to evaluate the safety of boceprevir or telaprvir in addition to pegylated interferon and ribavirin for the treatment of chronic Hepatitis C in patients with bleeding disorders

  • Sasadeusz, Joseph (Primary Chief Investigator (PCI))
  • Audsley, Jennifer (Chief Investigator (CI))
  • Lewin, Sharon (Chief Investigator (CI))
  • Strasser, Simone Irene (Chief Investigator (CI))
  • Wright, Edwina (Chief Investigator (CI))
  • Tran, Huyen (Chief Investigator (CI))
  • Iser, David M. (Chief Investigator (CI))
  • Dunkley, Scott (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/13 → 31/12/13

Funding

  • Haemophilia Foundation Australia Inc: A$20,000.00